Cartesian Therapeutics, Inc.

8-K Shareholder vote results Jun 17, 2026 8-K Regulation FD disclosure Jun 9, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure May 26, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Director or officer change Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Mar 9, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Director or officer change; Item 5.05; Regulation FD disclosure Dec 18, 2025 8-K Regulation FD disclosure; Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure Oct 30, 2025 8-K Director or officer change Oct 21, 2025 8-K Director or officer change Oct 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 16, 2025 8-K Other events May 30, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 29, 2025 8-K Regulation FD disclosure; Other events Apr 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Regulation FD disclosure Mar 3, 2025 8-K Other events Jan 27, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Sep 26, 2024 8-K Shareholder vote results Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events Jul 2, 2024 8-K Director or officer change; Shareholder vote results Jun 17, 2024 8-K Regulation FD disclosure; Other events May 22, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024